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Abstract
Interstitial fluid pressure (IFP) has been shown to be an independent prognostic parameter for disease-free survival
in cervical carcinoma patients treated with radiation therapy. However, the underlying mechanisms are not fully
understood. The main aims of this study were to investigate whether tumor radiocurability may be associated with
IFP and, if so, to identify possible mechanisms. Human melanoma xenografts transplanted intradermally or in win-
dow chamber preparations in BALB/c nu/nu mice were used as preclinical tumor models. Radiation dose resulting
in 50% local tumor control was higher by a factor of 1.19 ± 0.06 in tumors with IFP≥ 9 mm Hg than in tumors with
IFP ≤ 7 mm Hg. Tumor IFP was positively correlated to vessel segment length and vessel tortuosity and was in-
versely correlated to vessel density. Compared with tumors with low IFP, tumors with high IFP showed high re-
sistance to blood flow, high frequency of PO2 fluctuations, and high fractions of acutely hypoxic cells, whereas the
fraction of radiobiologically hypoxic cells and the fraction of chronically hypoxic cells did not differ between tumors
with high and tumors with low IFP. IFP showed a significant correlation to the fraction of acutely hypoxic cells,
probably because both parameters were determined primarily by the microvascular resistance to blood flow.
Therefore, the observed association between tumor radiocurability and IFP was most likely an indirect conse-
quence of a strong relationship between IFP and the fraction of acutely hypoxic cells.
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Introduction
Interstitial fluid pressure (IFP) is generally higher in solid malignant
tumors than in the surrounding normal tissue [1]. Most experimental
and human tumors show IFP values of 5 to 40 mm Hg, whereas the
IFP of most normal tissues ranges from −3 to +3 mm Hg [2]. Ele-
vated IFP in tumors is a consequence of severe microvascular, lym-
phatic, and interstitial abnormalities [3]. Tumor tissues generally
show high geometric and viscous resistance to blood flow, high micro-
vascular hydrostatic pressure, low resistance to transcapillary fluid
flow, high resistance to interstitial fluid flow, and impaired lymphatic
drainage [3,4]. The microvascular hydrostatic pressure is the prin-
cipal driving force for interstitial hypertension in tumors [5]. Fluid
is forced from the microvasculature into the interstitium where it
accumulates, distends the elastic extracellular matrix, and causes an
elevation of the IFP [6]. A pseudostable state is established where the
central tumor IFP is nearly equal to the microvascular hydrostatic
pressure, resulting in reduced fluid flow through the interstitium
[7]. One important consequence is poor and heterogeneous uptake
of macromolecular therapeutic agents and, hence, tumor resistance to
some forms of gene therapy and immunotherapy [8].
Hypoxia is another characteristic feature of the physiological micro-
environment of solid malignant tumors [9]. Two main causes of tumor
hypoxia have been recognized: permanent limitations in oxygen dif-
fusion result in chronic hypoxia and transient limitations in blood
perfusion result in acute hypoxia [10]. Most assays of tumor hypoxia
do not distinguish between chronic and acute hypoxia, although the
biology of acutely hypoxic cells may differ from that of chronically
hypoxic cells [9]. Tumor hypoxia may cause resistance to radiation
therapy and some forms of chemotherapy and has been shown to
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be associated with malignant progression, increased incidence of
metastases, and poor prognosis [10–12]. Clinical studies involving sev-
eral histologic types of cancer have shown that patients with highly
hypoxic primary tumors may have increased frequency of locoregional
treatment failure and poor disease-free and overall survival rates after
radiation therapy alone or radiation therapy combined with surgery
and/or chemotherapy [12–14].
Although the association between outcome of radiation therapy
and tumor hypoxia has been investigated in a large number of clinical
studies, only one significant clinical study of the association between
IFP and patient outcome after radiation therapy has been reported
[15,16]. In this study, patients with locally advanced cervical carci-
noma were treated with radiation therapy alone, and IFP and oxygen
tension (PO2) were measured in the primary tumor before treatment.
The study showed that high IFP was associated with poor disease-free
survival independent of conventional prognostic factors, such as tu-
mor size, stage, and lymph node status. Patients with tumors with
high IFP had increased probability of developing both local (pelvis)
and distant (para-aortic lymph nodes, liver, lungs) recurrences. Inter-
estingly, the independent prognostic impact of IFP for recurrence
and survival was strong, whereas the independent prognostic impact
of tumor hypoxia was of borderline significance and was limited to
patients without nodal metastases [16].
The biological mechanisms by which IFP influences response to
radiation treatment, metastasis, and patient survival have not been
identified. However, several mechanisms have been suggested, in-
cluding the possibilities that tumors with high IFP may show a high
rate of cell proliferation, large temporal and spatial variations in blood
flow and oxygen tension, and a high secretion of cytokines that may
stimulate angiogenesis/lymphangiogenesis or cause endothelial cell ra-
diation resistance [3]. Identification of the mechanisms connecting
high IFP to poor patient outcome is essential to take full advantage
of IFP measurements in cancer diagnostics and treatment. Detailed
mechanistic studies can probably be performed only in adequate exper-
imental tumor systems.
Therapeutic and biological consequences of high tumor IFP are cur-
rently being investigated in our laboratory by using human melanoma
xenografts as preclinical models of human cancer [17,18]. Previously,
we have shown that high IFP promotes pulmonary and lymph node
metastasis in A-07 tumors by hypoxia-independent mechanisms [18].
The purpose of the work reported here was to investigate whether tu-
mor radiocurability may be associated with IFP. The study was based
on the hypothesis that tumors with high IFP may have high fractions
of acutely hypoxic cells and, hence, be resistant to radiation treatment.
The hypothesis was found to be valid by studying A-07 tumors trans-
planted intradermally or in window chamber preparations in athymic
nude mice. Compared with tumors with low IFP, tumors with high
IFP showed high radiation dose resulting in 50% local tumor control
(TCD50), high resistance to blood flow, high frequency of PO2 fluctua-
tions, and high fractions of acutely hypoxic cells, whereas the total frac-
tion of hypoxic cells and the fraction of chronically hypoxic cells did
not differ between tumors with high and tumors with low IFP.
Materials and Methods
Mice
Adult (8-10 weeks) female BALB/c nu/nu mice, bred and main-
tained as described elsewhere [19], were used as host animals for
xenografted tumors. The animal experiments were approved by the
institutional committee on research animal care and were done ac-
cording to the US Public Health Service Policy on Humane Care
and Use of Laboratory Animals.
Tumors
A-07 or A-07–green fluorescence protein (GFP) human melanoma
xenografts were used as tumor models [20,21]. Intradermal tumors
were initiated from monolayer cultures by inoculating aliquots of
approximately 3.5 × 105 A-07 cells into the left mouse flank [20].
Window chamber tumors were initiated from A-07-GFP multicellular
spheroids with a diameter of 100 to 200 μm [21]. The experiments
were carried out when the intradermal tumors had grown to a volume
of 250 to 350 mm3 and when the area of the window chamber tumors
was 10 to 15 mm2.
Anesthesia
Window chamber implantation, intravital microscopy, tumor irradi-
ation, IFP measurements, and PO2 measurements were carried out
with anesthetized mice. Fentanyl citrate (Janssen Pharmaceutica,
Beerse, Belgium), fluanisone (Janssen Pharmaceutica), and midazolam
(Hoffmann-La Roche, Basel, Switzerland) were administered intra-
peritoneally (IP) in doses of 0.63, 20, and 10 mg/kg, respectively.
By using the 86Rb uptake method, it has been verified that this an-
esthesia does not alter the blood perfusion of A-07 tumors signifi-
cantly [17]. After window chamber implantation, the mice were given
buprenorphine (Temgesic; Schering-Plough, Brussels, Belgium) IP in
a dose of 0.12 mg/kg. During experiments, the body core temperature
of the mice was kept at 37 to 38°C by using a heating lamp, a heating
pad, or a hot air generator.
Window Chamber Preparations and Intravital Microscopy
Window chambers were implanted into the dorsal skin fold of
mice as described earlier [21]. Briefly, the chamber consisted of
two parallel frames, and after implantation, the frames sandwiched
an extended double layer of skin. Before implantation, an approxi-
mately 6.0-mm circular hole was made in one of the skin layers. A
plastic window with a diameter of 6.0 mm in the frame on the sur-
gical side provided visual access to the tumor growing in the opposite
skin layer. Intravital microscopy was carried out by using an inverted
fluorescence microscope equipped with filters for green and red lights
(IX-71; Olympus, Munich, Germany), a black and white CCD camera
(C4742-95; Hamamatsu Photonics, Hamamatsu, Japan), and image
acquisition software (Wasabi; Hamamatsu Photonics). Tetramethyl-
rhodamine isothiocyanate–labeled dextran with a molecular weight
of 155 kDa (Sigma Aldrich, St. Louis, MO) was used as vascular tracer.
After a 0.2-ml bolus of tetramethylrhodamine isothiocyanate–labeled
dextran (50 mg/ml) had been injected into the lateral tail vein, the
entire vascular network was mapped at a pixel size of 3.4 × 3.4 μm2
by transillumination and fluorescence microscopy. Vessel density (vessel
length per squared millimeter tumor area), median vessel segment
length, and median vessel tortuosity were determined as described else-
where [21,22].
Interstitial Fluid Pressure Measurements
IFP was measured in the center of tumors by using the wick-in-
needle method for intradermal tumors and the Millar SPC 320 cathe-
ther for window chamber tumors as described earlier [17,18].
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Oxygen Tension Measurements
Tissue PO2 was measured simultaneously in two positions in each
tumor by using a two-channel fiber-optic oxygen-sensing device
(OxyLite 2000; Oxford Optronix, Oxford, UK) as described else-
where [23]. Briefly, after the PO2 probes had been inserted into
the tumor tissue, PO2 readings were recorded every 5 or 10 seconds
for at least 60 minutes and stored. At the end of an experiment, the
mouse was killed without withdrawing the probes from the tumor to
ensure that the PO2 dropped rapidly to 0 mm Hg. The mice were
watched continuously during PO2 acquisitions, and if reflex move-
ments occurred during an experiment, the experiment was inter-
rupted and the data discarded. Thirty-eight tumor-bearing mice
entered the study, and the PO2 acquisition was interrupted in two
mice because of reflex movements. The following parameters were
derived from the PO2 traces: mean PO2 (mm Hg), PO2 fluctuation
frequency (number per hour), absolute amplitude of each PO2 fluc-
tuation (mm Hg), and relative amplitude of each PO2 fluctuation
[23,24]. Previous studies in our laboratory have shown that changes
in PO2 recorded in tumor or muscle tissue during the first 20 min-
utes after the insertion of an OxyLite probe may represent artifacts
caused by the probe [23]. By summing 50 normalized PO2 traces re-
corded in A-07 tumors, it was observed that the PO2 changes re-
corded within the first 20 minutes were systematic and hence were
caused by the probe, whereas those recorded beyond the first 20 min-
utes were random and hence most likely represented true variations
in tissue PO2 [23]. Therefore, the PO2 values recorded during the first
20 minutes were excluded from analysis in the present work.
Irradiation
A Stabilipan x-ray unit (Siemens, Erlangen, Germany), operated at
220 kV, 19 to 20 mA, and with 0.5-mm Cu filtration, was used for
irradiation. The irradiation was performed by using a dose rate of
5.1 Gy/min and a radiation field of 15 × 15 mm [25]. Hypoxic tu-
mors were obtained by occluding the blood supply with a clamp
5 minutes before the radiation exposure.
TCD50 Assay
Tumors were examined twice weekly after irradiation and scored as
locally controlled if regrowth was not observed within 90 days after
the radiation treatment. The percentage of locally controlled tumors
was plotted versus radiation dose, and TCD50 was determined by prob-
ability regression analysis [19]. Probability regression analysis was used
because the cumulative distribution function of a normally distributed
variable can be shown as a straight line in a probability plot.
Cell Survival Assay
The cell survival of tumors irradiated in vivo was measured in vitro
by using a plastic surface colony assay [19]. Briefly, tumor cell suspen-
sions, prepared by using a standardized mechanical and enzymatic pro-
cedure, were plated in tissue culture flasks and incubated for 14 days.
The cell surviving fraction of an irradiated tumor was calculated from
the plating efficiency of the cells of the tumor and the mean plating
efficiency of the cells of six unirradiated tumors. The plating efficiency
of the unirradiated control tumors ranged from 30% to 50%.
Fraction of Radiobiologically Hypoxic Cells
The fraction of radiobiologically hypoxic cells was determined for
individual tumors by using an experimental procedure based on the
paired survival curve method [25]. The tumors were irradiated with
10 Gy under unclamped conditions, and the fraction of surviving
cells (SF10 [unclamped]) was determined for each tumor as previ-
ously mentioned. The fraction of radiobiologically hypoxic cells
was calculated as SF10 (unclamped)/SF10 (clamped), where SF10
(clamped) represents the mean cell surviving fraction of ten tumors
irradiated with 10 Gy under clamped conditions. The determination
of the fraction of radiobiologically hypoxic cells of individual A-07
tumors from measurements of SF10 has been justified previously
[25]. The theoretical basis for the paired survival curve method has
been described in detail by Hall in his textbook on basic radiation
biology [26].
Fraction of Chronically Hypoxic Cells
The fraction of chronically hypoxic cells was measured for individ-
ual tumors by using a peroxidase-based immunohistochemical assay,
optimized with the purpose of staining chronically hypoxic cells ad-
equately without staining normoxic or acutely hypoxic cells signifi-
cantly. The assay and a critical evaluation of the assay have been
reported elsewhere [25]. Briefly, pimonidazole [1-[(2-hydroxy-3-
piperidinyl)-propyl]-2-nitroimidazole], a well-characterized hypoxia
marker [27], was administered IP in doses of 30 mg/kg 4 hours be-
fore tumor resection. Histologic preparations, produced from tumor
tissue fixed in phosphate-buffered 4% paraformaldehyde, were incu-
bated with polyclonal rabbit antiserum to pimonidazole-protein ad-
ducts. Diaminobenzidine was used as a chromogen, and hematoxylin
was used for counterstaining. Quantitative studies of hypoxia were
based on six cross sections of each tumor. The fraction of chronically
hypoxic cells (i.e., the area fraction of the tissue showing positive
pimonidazole staining) was determined by image analysis.
Fraction of Acutely Hypoxic Cells
The fraction of acutely hypoxic cells (HFAcu) was calculated from
the fraction of radiobiologically hypoxic cells (HFRad) and the frac-
tion of chronically hypoxic cells (HFChr) as HFAcu = HFRad − HFChr.
Thus, HFRad, HFChr, and the difference between HFRad and HFChr
were assumed to represent the total fraction of hypoxic cells, the frac-
tion of chronically hypoxic cells, and the fraction of acutely hypoxic
cells, respectively. These assumptions have been verified to be valid
for human melanoma xenografts [25,28,29].
Statistical Analysis
Correlations between variables were searched for by regression
analysis (linear correlations) or by using the Spearman rank-order
correlation test (nonlinear correlations). Statistical comparisons of
data were carried out by using the Student’s t test when the data
complied with the conditions of normality and equal variance and
otherwise by nonparametric analysis using the Mann-Whitney rank
sum test. Probability values of P < .05, determined from two-sided
tests, were considered significant. The statistical analysis was per-
formed by using the SigmaStat statistical software (Jandel Scientific
GmbH, Erkrath, Germany).
Results
The Radiocurability of A-07 Tumors Is Associated with IFP
To investigate whether tumor radiocurability may be associated with
IFP, TCD50 was determined for intradermal A-07 tumors with low
IFP (IFP ≤ 7 mm Hg) and high IFP (IFP ≥ 9 mm Hg). Two hundred
tumor-bearing mice were included in the experiment. The volume of
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the tumors with low IFP (312 ± 19 mm3) was not significantly dif-
ferent from that of the tumors with high IFP (303 ± 22 mm3; P >
.05). IFP was measured immediately before the tumors were exposed
to single-dose irradiation. TCD50 was found to be higher for tumors
with high IFP than for tumors with low IFP by a factor of 1.19 ±
0.06 (Figure 1; P = .000049). The numerical values of TCD50 (mean
[95% confidence interval]) for the two tumor groups were 37.7 Gy
(34.8-40.4 Gy) and 31.7 Gy (29.5-33.4 Gy).
IFP Is Correlated to Vessel Segment Length and Vessel
Tortuosity and Inversely Correlated to Vessel Density
in A-07-GFP Tumors
To explore possible mechanisms leading to high IFP in tumors, the
morphology of the microvascular network was characterized for five
A-07-GFP window chamber tumors varying widely in IFP. Qualita-
tive studies revealed that the network differed substantially between
tumors with low IFP and tumors with high IFP (Figure 2A). Quan-
titative analysis showed that IFP decreased with increasing vessel
density and increased with increasing vessel segment length and in-
creasing vessel tortuosity (Figure 2B). Significant correlations were
found between IFP and vessel density (P = .0084) and IFP and vessel
segment length (P = .017), whereas the relationship between IFP and
vessel tortuosity was of borderline significance (P = .083).
High IFP Is Associated with a High Frequency of PO2
Fluctuations in A-07 Tumors
To search for possible associations between IFP and PO2, IFP and
PO2 were recorded in the same intradermal A-07 tumors. Thirty-six
tumors were included in the experiment. Median IFP of the tumors
was 7.3 mm Hg. The volume of the tumors with IFP below the me-
dian value (306 ± 23 mm3) was not significantly different from that
of the tumors with IFP above the median value (293 ± 27 mm3; P >
.05). The PO2 traces differed substantially between tumors with low
IFP and tumors with high IFP (Figure 2C ). The tumors with IFP
above the median value showed a higher frequency of PO2 fluctua-
tions than the tumors with IFP below the median value (Figure 2D;
P = .031). Mean PO2 and the absolute and relative amplitudes of the
PO2 fluctuations did not differ between the two tumor groups (P >
.05 for all parameters). The PO2 traces showed no general trend for
increasing or decreasing PO2 with time. The numerical values derived
from the first 20 minutes of the PO2 traces were not significantly
different from those derived from the last 20 minutes, regardless of
whether mean PO2, PO2 fluctuation frequency, absolute amplitude of
each PO2 fluctuation, or relative amplitude of each PO2 fluctuation
was considered (P > .05 for all parameters).
IFP Is Correlated to the Fraction of Acutely Hypoxic Cells But
Not to the Fraction of Radiobiologically Hypoxic Cells or to the
Fraction of Chronically Hypoxic Cells in A-07 Tumors
To investigate whether IFP may be correlated to the fraction of
radiobiologically hypoxic cells, the fraction of chronically hypoxic
cells, and/or the fraction of acutely hypoxic cells, these four param-
eters were determined for 20 intradermal A-07 tumors. IFP was
recorded immediately before the tumors were exposed to a single ra-
diation dose of 10 Gy under unclamped conditions. After the radi-
ation exposure, the tumors were resected and cut into approximately
1-mm-thick slices. One half of each tumor (every second slice) was
processed for measurement of SF10 (unclamped) and the fraction of
radiobiologically hypoxic cells, whereas the other half was processed
for detection of pimonidazole-positive cells and assessment of the
fraction of chronically hypoxic cells. The fraction of acutely hypoxic
cells was then calculated as described above.
SF10 (unclamped) differed by a factor of approximately 75, from
4.5 × 10−4 to 3.4 × 10−2, among the 20 tumors, whereas SF10
(clamped) of 10 control tumors and SF20 (clamped) of 10 control
tumors differed by factors of approximately 1.8 and 2.2, respectively
(Figure 3). The geometric means of SF10 (unclamped), SF10 (clamped),
and SF20 (clamped), indicated by horizontal lines in Figure 3, were
1.1 × 10−2, 9.0 × 10−2, and 1.4 × 10−3, respectively. The coefficients
of variation were 69% (SF10 [unclamped]), 17% (SF10 [clamped]),
and 25% (SF20 [clamped]). The differences in SF10 (unclamped)
among the tumors thus primarily reflected differences in the frac-
tion of radiobiologically hypoxic cells and not experimental uncer-
tainty. The fraction of radiobiologically hypoxic cells differed from
0.5% to 37.6%, with a geometric mean of 12% and an arithmetic
mean of 17%.
The fraction of chronically hypoxic cells differed among the 20 tu-
mors from 0.0% to 31.5% with mean and median values of 8.2% and
4.8%, respectively. The fraction of acutely hypoxic cells was higher
than the fraction of chronically hypoxic cells in 13 of the 20 tumors
and ranged from 0.5% to 35.1% with mean and median values of
8.8% and 5.3%, respectively. There was no positive or inverse corre-
lation between the fraction of acutely hypoxic cells and the fraction of
chronically hypoxic cells in the tumors (Figure 4; P > .05).
IFP differed among the 20 tumors from 2.0 to 17.5 mm Hg with
a median value of 8.0 mm Hg. The tumors with IFP above the me-
dian value did not differ from those with IFP below the median value
Figure 1. Local tumor control versus radiation dose and irradiation
time for intradermal A-07 tumors with IFP≤ 7 mm Hg (•) and IFP ≥
9mmHg (○). Points indicate percentage of locally controlled tumors,
based on 20 tumor-bearing mice; solid curves, curves fitted to the
data by probability regression analysis; dotted curves, 95%confidence
intervals; horizontal lines, the 95% confidence intervals of TCD50.
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Figure 2. (A) Vascular morphology of two A-07-GFP window chamber tumors with IFP of 2.2 and 17.4 mm Hg shown at low (left) and
high (right) magnifications. (B) IFP versus vessel density, median vessel segment length, and median vessel tortuosity for A-07-GFP
window chamber tumors. Points indicate individual tumors; curves, curves fitted to the data by regression analysis. (C) Representative
PO2 traces for intradermal A-07 tumors with low (black curves) or high (red and blue curves) IFP. Time zero refers to 20 minutes after the
probe insertion because the PO2 values recorded before this time point were influenced by artifacts caused by the probe and hence
were excluded from analysis. (D) PO2 fluctuation frequency for intradermal A-07 tumors with IFP < 7.3 mm Hg (low) and IFP > 7.3 mm Hg
(high). Points indicate individual tumors; horizontal lines, mean values.
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in the fraction of radiobiologically hypoxic cells (Figure 5A; P > .05)
or in the fraction of chronically hypoxic cells (Figure 5A; P > .05),
whereas the fraction of acutely hypoxic cells was higher for the tu-
mors with high IFP than for those with low IFP (Figure 5A; P =
.038). Furthermore, there was no correlation between IFP and the
fraction of radiobiologically hypoxic cells (Figure 5B; P > .05) or be-
tween IFP and the fraction of chronically hypoxic cells (Figure 5B;
P > .05). Conversely, IFP increased linearly with the increasing frac-
tion of acutely hypoxic cells (Figure 5B; P = .000014).
Discussion
The radiocurability of tumors has been shown to depend on several
biological and physiological parameters, including number of clono-
genic cells, fraction of hypoxic cells, rate of cell proliferation, and cel-
lular radiation sensitivity [30]. The present work shows that tumor
radiocurability also may be associated with IFP. In A-07 human mel-
anoma xenografts, TCD50 was found to be significantly higher for
tumors with high IFP than for tumors with low IFP. This is a novel
observation that may have significant implications for the radiation
therapy of cancer. Furthermore, the main underlying mechanism was
identified by studying relationships between IFP and PO2 fluctua-
tions using fiber-optic oxygen-sensing probes, between IFP and hyp-
oxia using assays discriminating between chronically and acutely
hypoxic cells, and between IFP and microvascular morphology using
tumors transplanted into dorsal skin fold window chambers.
The A-07 melanoma line was chosen for this study for several rea-
sons. It has been shown that the experimental procedures used here
give highly reproducible results for tumors of this line, and the un-
derlying assumptions have been verified to be valid for A-07 tumors
[17–25,28,29]. Moreover, the IFP of A-07 tumors can be measured
reliably in a single location in the tumor center because the IFP is
uniform throughout the tumors except close to the surface, where
it drops precipitously to normal tissue values [18]. Finally, A-07 tu-
mors of the size used here do not develop regions with necrotic tis-
sue and show fractions of chronically hypoxic cells and fractions of
acutely hypoxic cells that are of approximately the same magnitude
[25,28,29].
On the basis of previous experience with A-07 tumors [31], the
TCD50 values reported here were obtained by using a dose rate of
5.1 Gy/min and single-radiation doses ranging from 25 to 46 Gy,
implying that the exposure time varied among the tumors from
approximately 5 to 9 minutes. In comparison, the number of PO2
fluctuations per hour varied between 0 and 7, and consistent with
previous studies [23], the duration of the acute hypoxia periods
was short compared with the irradiation times. Thus, most periods
in which PO2 was acutely less than 5 mm Hg had a duration of less
than 2 minutes. Furthermore, the PO2 fluctuations recorded simul-
taneously in two different positions in the tumors were not coordi-
nated as described previously for A-07 tumors [23]. Consequently, it
is unlikely that the fractional time the tumor cells were acutely hyp-
oxic during the radiation exposure varied consistently with the radi-
ation dose and thus influenced the TCD50 values. It should also be
noticed that similar dose ranges were used for tumors with low IFP
and tumors with high IFP.
A-07 window chamber tumors with high IFP showed low vessel
density, long vessel segment lengths, and high vessel tortuosity. Tor-
tuous and elongated vessels resist blood flow, are often leaky, and may
cause hemoconcentration and intravascular coagulation [32]. Tumor
microvascular networks characterized by long vessel segment lengths
and high vessel tortuosity have high viscous and geometric resistance
to blood flow, high intravessel hydrostatic pressure, and show low
blood flow velocities [32,33]. Consequently, high IFP in A-07 tu-
mors was most likely a result of high microvascular hydrostatic pres-
sure and low resistance to transcapillary fluid flow caused by severe
morphologic abnormalities in the microvascular network. This sug-
gestion is consistent with earlier studies having shown that the mi-
crovasculature of A-07 tumors has a high frequency of endothelial
Figure 3. Cell surviving fraction versus radiation dose for intradermal
A-07 tumors irradiatedunder clamped (•) or unclampedconditions (○).
Points indicate individual tumors; horizontal lines, geometric means.
Figure 4. Fraction of acutely hypoxic cells (HFAcu) versus the fraction
of chronically hypoxic cells (HFChr) for intradermal A-07 tumors.
Points indicate individual tumors; line, line indicating HFAcu = HFChr.
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fenestrae and large interendothelial gaps, incomplete endothelial lin-
ing, and discontinuous basement membrane [20] and shows high ef-
fective permeability constants for macromolecules [34,35].
Furthermore, A-07 tumors with high IFP showed a high frequency
of PO2 fluctuations. Fluctuations in PO2 in tumors are primarily a
result of fluctuations in blood flow [36]. Previous studies have shown
that fluctuations in microvessel blood flow occur frequently in A-07
tumors and are due to vasomotor activity in tumor-supplying arte-
rioles, mechanical compression of vessel walls caused by proliferating
tumor cells, intravascular stasis and clot formation, and vessel obstruc-
tion caused by circulating white blood cells [37]. It is conceivable that
tumors with high resistance to blood flow show a particularly high fre-
quency of blood flow fluctuations [36]. Consequently, the association
between high IFP and high frequency of PO2 fluctuations was most
likely a result of both parameters being determined primarily by the
geometric and viscous resistance to blood flow.
The association between tumor radiocurability and IFP observed
here may thus be explained in the following way. First, high geometric
Figure 5. (A) The fraction of radiobiologically hypoxic cells (HFRad), the fraction of chronically hypoxic cells (HFChr), and the fraction of
acutely hypoxic cells (HFAcu) for intradermal A-07 tumors with IFP < 8.0 mm Hg (low) and IFP > 8.0 mm Hg (high). Points indicate
individual tumors; horizontal lines, mean values. (B) IFP versus HFRad, HFChr, and HFAcu for intradermal A-07 tumors. Points indicate
individual tumors; curve, curve fitted to the data by linear regression analysis.
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and viscous resistance to blood flow resulted in a high microvascular
hydrostatic pressure, and high microvascular hydrostatic pressure and
low transvascular resistance to fluid flow resulted in high IFP. Second,
high geometric and viscous resistance to blood flow resulted in low
blood flow velocity and high frequency of blood flow fluctuations,
high frequency of blood flow fluctuations resulted in a high fre-
quency of PO2 fluctuations, a high frequency of PO2 fluctuations re-
sulted in high fractions of acutely hypoxic cells, and high fractions of
acutely hypoxic cells resulted in high TCD50. Therefore, the present
association between high IFP and high TCD50 was most likely pri-
marily an indirect consequence of a strong correlation between the
fraction of acutely hypoxic cells and IFP.
Earlier studies have also investigated the relation between the IFP
of tumors and tumor oxygenation, both in patients with cervical car-
cinoma [15,16] and in experimental tumor models [38–40]. These
studies failed to demonstrate any correlation between IFP and hyp-
oxia, possibly because tumor hypoxia was assessed with assays that do
not discriminate between chronic and acute hypoxia. The observa-
tions reported here are thus not inconsistent with these earlier stud-
ies. Also, in the present study, there was no correlation between IFP
and total fraction of hypoxic cells as assessed by a radiobiological assay.
The geometric resistance to blood flow in the microvasculature of
tumors is a complex function of the geometric resistance of the in-
dividual vessel segments and the overall architecture of the network
[32]. Several morphologic and architectural parameters influencing
the geometric resistance have been identified and quantitated [1,6].
However, to our knowledge, quantitative studies linking geometric
resistance to blood flow, and hence IFP, to multiple microvascular
parameters have not been reported for any tumor thus far. The IFP
of the A-07 window chamber tumors studied here ranged from 2.2
to 17.4 mm Hg. This nearly eight-fold difference in IFP was coupled
to an approximately 0.7-fold difference in vessel density, a 1.6- to 1.7-
fold difference in vessel segment length, and an approximately 1.5-fold
difference in vessel tortuosity. This observation suggests that relatively
modest differences among tumors in microvascular parameters may
lead to significant differences in geometric resistance to blood flow
and, hence, significant differences in IFP.
Clinical studies have suggested that tumor IFP may be a strong
prognostic parameter for patients treated with radiation therapy
[15,16]. Associations between patient outcome and IFP may be an
indirect result of associations between patient outcome and tumor
oxygenation because the present work suggests that high IFP and
high fraction of acutely hypoxic cells in tumors may have high resis-
tance to blood flow as a common cause, and associations between
tumor radiocurability and IFP may be an indirect consequence of
associations between tumor radiocurability and fraction of acutely
hypoxic cells. However, high IFP may also have impacts on patient
outcome, which are independent of tumor hypoxia. Studies in our
laboratory have thus shown that high IFP in the primary tumor pro-
motes pulmonary and lymph node metastasis in small human mela-
noma xenografts without hypoxic cells [18]. It is also highly unlikely
that the poor and heterogeneous uptake of macromolecular chemo-
therapeutic agents seen in tumors with high IFP is influenced signifi-
cantly by acute hypoxia per se [8]. Furthermore, the present work does,
of course, not exclude the possibility that high IFP also may influence
tumor radiocurability by hypoxia-independent mechanisms.
Our observation that both high IFP and high fraction of acutely
hypoxic cells in tumors may be a consequence of long vessel segment
lengths and high vessel tortuosity, gives strong support to the sugges-
tion that the tumor microvascular network may be an important tar-
get for novel therapeutic strategies. The antivascular therapeutic
strategies currently under development aim at inhibiting angiogene-
sis, disrupting the microvascular network, or normalizing the micro-
vasculature [41]. Viewed in the light of the observations reported
here, strategies making use of antiangiogenic agents that may normal-
ize the microvasculature are particularly interesting, also because it
has been shown that the treatment of cancer with such agents may
decrease tumor IFP and improve tumor oxygenation [42].
In summary, high TCD50 was found to be associated with high
IFP in A-07 human melanoma xenografts. This association was prob-
ably an indirect consequence of a significant correlation between IFP
and the fraction of acutely hypoxic cells. The correlation between
IFP and the fraction of acutely hypoxic cells was most likely a result
of both parameters being determined primarily by the vessel segment
length and the vessel tortuosity and, hence, the geometric and vis-
cous resistance to blood flow. These observations suggest that asso-
ciations between treatment outcome and tumor IFP for patients
given radiation therapy may be an indirect result of associations be-
tween patient outcome and tumor oxygenation.
Acknowledgments
The authors thank Kristin Henriksen, Edrun Andrea Schnell, Kristil
Kindem, and Else-Beate M. Ruud for technical assistance.
References
[1] Heldin CH, Rubin K, Pietras K, and Östman A (2004). High interstitial fluid
pressure—an obstacle in cancer therapy. Nat Rev Cancer 4, 806–813.
[2] Fukumura D and Jain RK (2007). Tumor microenvironment abnormalities:
causes, consequences, and strategies to normalize. J Cell Biochem 101, 937–949.
[3] Lunt SJ, Fyles A, Hill RP, and Milosevic M (2008). Interstitial fluid pressure in tu-
mors: therapeutic barrier and biomarker of angiogenesis. Future Oncol 4, 793–802.
[4] Cairns R, Papandreou I, and Denko N (2006). Overcoming physiologic barriers
to cancer treatment by molecularly targeting the tumor microenvironment. Mol
Cancer Res 4, 61–70.
[5] Boucher Y and Jain RK (1992). Microvascular pressure is the principal driving
force for interstitial hypertension in solid tumors: implications for vascular col-
lapse. Cancer Res 52, 5110–5114.
[6] Milosevic M, Fyles A, and Hill RP (1999). The relationship between elevated
interstitial fluid pressure and blood flow in tumors: a bioengineering analysis. Int
J Radiat Oncol Biol Phys 43, 1111–1123.
[7] Milosevic M, Fyles A, Hedley D, and Hill RP (2004). The human tumor micro-
environment: invasive (needle) measurement of oxygen and interstitial fluid pres-
sure. Semin Radiat Oncol 14, 249–258.
[8] Jain RK (1996). Delivery of molecular medicine to solid tumors. Science 271,
1079–1080.
[9] Höckel M and Vaupel P (2001). Tumor hypoxia: definitions and current clin-
ical, biologic, and molecular aspects. J Natl Cancer Inst 93, 266–276.
[10] Brown JM and Giaccia AJ (1998). The unique physiology of solid tumors: op-
portunities (and problems) for cancer therapy. Cancer Res 58, 1408–1416.
[11] Rofstad EK (2000). Microenvironment-induced cancer metastasis. Int J Radiat
Biol 76, 589–605.
[12] Harris AL (2002). Hypoxia—a key regulatory factor in tumour growth. Nat Rev
Cancer 2, 38–47.
[13] Vaupel P (2004). Tumor microenvironmental physiology and its implications
for radiation oncology. Semin Radiat Oncol 14, 198–206.
[14] Vaupel P and Mayer A (2007). Hypoxia in cancer: significance and impact on
clinical outcome. Cancer Metastasis Rev 26, 225–239.
[15] Milosevic M, Fyles A, Hedley D, Pintilie M, Levin W, Manchul L, and Hill RP
(2001). Interstitial fluid pressure predicts survival in patients with cervix cancer
independent of clinical prognostic factors and tumor oxygen measurements.
Cancer Res 61, 6400–6405.
[16] Fyles A, Milosevic M, Pintilie M, Syed A, Levin W, Manchul L, and Hill RP
(2006). Long-term performance of interstitial fluid pressure and hypoxia as
prognostic factors in cervix cancer. Radiother Oncol 80, 132–137.
1250 Radiocurability and Interstitial Fluid Pressure Rofstad et al. Neoplasia Vol. 11, No. 11, 2009
[17] Gulliksrud K, Brurberg KG, and Rofstad EK (2009). Dynamic contrast-enhanced
magnetic resonance imaging of tumor interstitial fluid pressure. Radiother Oncol
91, 107–113.
[18] Rofstad EK, Tunheim SH, Mathiesen B, Graff BA, Halsør EF, Nilsen K, and
Galappathi K (2002). Pulmonary and lymph node metastasis is associated with
primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer
Res 62, 661–664.
[19] Rofstad EK (1991). Influence of cellular radiation sensitivity on local tumor
control of human melanoma xenografts given fractionated radiation treatment.
Cancer Res 51, 4609–4612.
[20] Rofstad EK (1994). Orthotopic human melanoma xenograft model systems for
studies of tumour angiogenesis, pathophysiology, treatment sensitivity and met-
astatic pattern. Br J Cancer 70, 804–812.
[21] Gaustad JV, Simonsen TG, Brurberg KG, Huuse EM, and Rofstad EK (2009).
Blood supply in melanoma xenografts is governed by the morphology of the
supplying arteries. Neoplasia 11, 277–285.
[22] Gaustad JV, Brurberg KG, Simonsen TG, Mollatt CS, and Rofstad EK (2008).
Tumor vascularity assessed by magnetic resonance imaging and intravital micros-
copy imaging. Neoplasia 10, 354–362.
[23] Brurberg KG, Graff BA, and Rofstad EK (2003). Temporal heterogeneity in
oxygen tension in human melanoma xenografts. Br J Cancer 89, 350–356.
[24] Brurberg KG, Graff BA, Olsen DR, and Rofstad EK (2004). Tumor-line specific
PO2 fluctuations in human melanoma xenografts. Int J Radiat Oncol Biol Phys
58, 403–409.
[25] Rofstad EK and Måseide K (1999). Radiobiological and immunohistochemical
assessment of hypoxia in human melanoma xenografts: acute and chronic hyp-
oxia in individual tumours. Int J Radiat Biol 75, 1377–1393.
[26] Hall E (2000). Radiobiology for the Radiologist. Philadelphia, PA: Lippincott
Williams & Wilkins.
[27] Raleigh JA, Dewhirst MW, and Thrall DE (1996). Measuring tumor hypoxia.
Semin Radiat Oncol 6, 37–45.
[28] Gulliksrud K, Vestvik IK, Galappathi K, Mathiesen B, and Rofstad EK (2008).
Detection of hypoxic cell subpopulations in human melanoma xenografts by
pimonidazole immunohistochemistry. Radiat Res 170, 638–650.
[29] Rofstad EK, Galappathi K, Mathiesen B, and Ruud EBM (2007). Fluctuating
and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin Cancer Res
13, 1971–1978.
[30] Peters LJ, Brock WA, Chapman JD, and Wilson G (1998). Predictive assays of
tumor radiocurability. Am J Clin Oncol 11, 275–287.
[31] Rofstad EK and Måseide K (1998). Fraction of radiobiologically hypoxic cells in
human melanoma xenografts measured by using single-cell survival, tumour
growth delay and local tumour control as end points. Br J Cancer 78, 893–898.
[32] Jain RK (1998). Determinants of tumor blood flow: a review. Cancer Res 48,
2641–2658.
[33] Vaupel P, Kallinowski F, and Okunieff P (1989). Blood flow, oxygen and nutri-
ent supply, and metabolic microenvironment of human tumors. Cancer Res 49,
6449–6465.
[34] Bjørnæs I and Rofstad EK (2001). Microvascular permeability to macromol-
ecules in human melanoma xenografts assessed by contrast-enhanced MRI—
intertumor and intratumor heterogeneity. Magn Reson Imaging 19, 723–730.
[35] Graff BA, Vangberg L, and Rofstad EK (2004). Quantitative assessment of up-
take and distribution of iron oxide particles (NC 100150) in human melanoma
xenografts by contrast-enhanced MRI. Magn Reson Med 51, 727–735.
[36] Dewhirst MW, Cao Y, and Möller B (2008). Cycling hypoxia and free radicals
regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8, 425–437.
[37] Brurberg KG, Gaustad JV, Mollatt CS, and Rofstad EK (2008). Temporal hetero-
geneity in blood supply in human tumor xenografts. Neoplasia 10, 727–735.
[38] Boucher Y, Lee I, and Jain RK (1995). Lack of general correlation between in-
terstitial fluid pressure and oxygen partial pressure in solid tumors. Microvasc Res
50, 175–182.
[39] Tufto I, Lyng H, and Rofstad EK (1996). Interstitial fluid pressure, perfusion
rate and oxygen tension in human melanoma xenografts. Br J Cancer Suppl 27,
S252–S255.
[40] Lunt SJ, Kalliomäki TMK, Brown A, Yang VX, Milosevic M, and Hill RP
(2008). Interstitial fluid pressure, vascularity and metastasis in ectopc, orthotopic
and spontaneous tumours. BMC Cancer 8, 2.
[41] Heath VL and Bicknell R (2009). Anticancer strategies involving the vascula-
ture. Nat Rev Clin Oncol 6, 395–404.
[42] Jain RK (2005). Normalization of tumor vasculature: an emerging concept in
antiangiogenic therapy. Science 307, 58–62.
Neoplasia Vol. 11, No. 11, 2009 Radiocurability and Interstitial Fluid Pressure Rofstad et al. 1251
